ROYALTY PHARMA PLC shareholders Q3 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Rokos Capital Management LLP 1,106,813$29,612,7820.22%
Trexquant Investment LP 314,655$8,539,7370.21%
Jump Financial, LLC 203,000$5,509,4200.21%
Portolan Capital Management 78,352$2,126,4730.20%
TWINBEECH CAPITAL LP 363,291$9,859,7180.19%
Linden Thomas Advisory Services, LLC 28,823$782,2560.17%
GSA CAPITAL PARTNERS LLP 70,791$1,9210.16%
TWO SIGMA INVESTMENTS, LP 2,206,715$59,890,2450.16%
CORNERCAP INVESTMENT COUNSEL INC 32,449$880,6660.16%
Values First Advisors, Inc. 8,811$239,1210.15%
HORIZON KINETICS ASSET MANAGEMENT LLC 287,255$7,796,1010.15%
Executive Wealth Management, LLC 51,027$1,384,8870.14%
Handelsbanken Fonder AB 931,636$25,2850.14%
DARK FOREST CAPITAL MANAGEMENT LP 66,710$1,810,5090.14%
TWO SIGMA ADVISERS, LP 1,999,300$54,261,0020.14%
MORGAN STANLEY 48,132,615$1,306,319,2180.13%
Alaska Permanent Fund Corp 247,112$6,706,6200.13%
Mitsubishi UFJ Trust & Banking Corp 1,828,883$49,635,8850.12%
Qube Research & Technologies Ltd 1,710,872$46,433,0660.12%
Graypoint LLC 43,995$1,194,0240.11%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.